US-based Pfizer and Ireland's Allergan will be merging. The deal which is expected to close by 2016 would make the new company the world's largest drug manufacturer. How that will affect their earnings remains to be seen. http://rapidnewsnetwork.com/pfizer-deal-to-purchase-allergan-could-close-by-end-of-2016/312801/ Allergan CEO Brent Saunders will become president and chief operating officer of the combined company with oversight of all commercial businesses. Pfizer shareholders would control of 56 percent of the combined company . . . the tactic is primarily motivated by the disparity between the US’s high 35% corporate rate and the UK’s 20% rate, brought in by the coalition to attract additional business to the UK.